Daiichi Sankyo Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3475350009
JPY
2,805.00
53 (1.93%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Astellas Pharma, Inc.
Kyowa Kirin Co., Ltd.
Shionogi & Co., Ltd.
Ono Pharmaceutical Co., Ltd.
Otsuka Holdings Co., Ltd.
Chugai Pharmaceutical Co., Ltd.
Daiichi Sankyo Co., Ltd.
Eisai Co., Ltd.
Kobayashi Pharmaceutical Co., Ltd.
Takeda Pharmaceutical Co., Ltd.
Taisho Pharmaceutical Holdings Co., Ltd.

Why is Daiichi Sankyo Co., Ltd. ?

1
Low Debt Company with Strong Long Term Fundamental Strength
  • Healthy long term growth as Net Sales has grown by an annual rate of 16.32% and Operating profit at 33.85%
  • The company is Net-Debt Free
  • The company has been able to generate a Return on Capital Employed (avg) of 15.44% signifying high profitability per unit of total capital (equity and debt)
2
Flat results in Jun 26
  • INTEREST(9M) At JPY 8,964 MM has Grown at 5.5%
  • NET PROFIT(HY) At JPY 111,065 MM has Grown at -35.67%
  • DEBT-EQUITY RATIO (HY) Highest at -8.07 %
3
With ROE of 17.81%, it has a fair valuation with a 2.74 Price to Book Value
  • The stock is trading at a premium compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of -23.56%, its profits have risen by 24.1% ; the PEG ratio of the company is 0.6
4
Majority shareholders : Non Institution
5
Underperformed the market in the last 1 year
  • Even though the market (Japan Nikkei 225) has generated returns of 59.79% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -23.56% returns
stock-recommendationReal-Time Research Report

Verdict Report

How much should you hold?

  1. Overall Portfolio exposure to Daiichi Sankyo Co., Ltd. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Daiichi Sankyo Co., Ltd. for you?

Medium Risk, High Return

Absolute
Risk Adjusted
Volatility
Daiichi Sankyo Co., Ltd.
-20.99%
109.31
39.69%
Japan Nikkei 225
60.14%
2.04
29.37%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
16.32%
EBIT Growth (5y)
33.85%
EBIT to Interest (avg)
14.68
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.37
Sales to Capital Employed (avg)
1.01
Tax Ratio
1.36%
Dividend Payout Ratio
55.54%
Pledged Shares
0
Institutional Holding
0.00%
ROCE (avg)
16.62%
ROE (avg)
9.72%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
15
Industry P/E
Price to Book Value
2.74
EV to EBIT
14.26
EV to EBITDA
11.52
EV to Capital Employed
3.03
EV to Sales
2.17
PEG Ratio
0.56
Dividend Yield
NA
ROCE (Latest)
21.25%
ROE (Latest)
17.81%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
No Trend
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

4What is working for the Company
INVENTORY TURNOVER RATIO(HY)

Highest at 1.08 times

NET SALES(Q)

At JPY 574,740 MM has Grown at 21.1%

-6What is not working for the Company
INTEREST(9M)

At JPY 8,964 MM has Grown at 5.5%

NET PROFIT(HY)

At JPY 111,065 MM has Grown at -35.67%

DEBT-EQUITY RATIO (HY)

Highest at -8.07 %

Here's what is working for Daiichi Sankyo Co., Ltd.

Net Sales
At JPY 574,740 MM has Grown at 21.1%
Year on Year (YoY)
MOJO Watch
Near term sales trend is positive

Net Sales (JPY MM)

Inventory Turnover Ratio
Highest at 1.08 times
in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its inventory faster

Inventory Turnover Ratio

Here's what is not working for Daiichi Sankyo Co., Ltd.

Net Profit
At JPY 111,065 MM has Grown at -35.67%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is negative

Net Profit (JPY MM)

Debt-Equity Ratio
Highest at -8.07 % and Grown
In each half year in the last five Semi-Annual periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Interest
At JPY 8,964 MM has Grown at 5.5%
over previous Semi-Annual period
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (JPY MM)